Abstract

PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2013 - Volume 17, Number 5

View All Articles in Issue

Page(s): 356

Download in electronic PDF format for $75

Abstract

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Sep/Oct 2013 Pg. 356	PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 210-219	Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 351 View Sample	Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 101-111	Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective Author(s): Timko Robert J, Crooker Philip EM
Jan/Feb 2013 Pg. 87	PostScription: GMPs and GCPs: A Topical Comparison Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 356	PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 373-380	Documentation: Records and Reports Author(s): Akers Michael J
Sep/Oct 2013 Pg. 439	PostScription: GMPs vs. GCPs: United States Pharmacopeia General Chapters Author(s): Allen Loyd V Jr
Jul/Aug 2015 Pg. 303-305	U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Author(s): Miller David G
Mar/Apr 2017 Pg. 95-102	U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Author(s): Yoch Doug
Nov/Dec 2015 Pg. 487-488	U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 401-404	Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 Author(s): Martin Matt
Mar/Apr 1997 Pg. 75-77	NABP Guidelines: Good Compounding Practices Applicable to State-Licensed Pharmacies Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 453-463	Applying Quality of Design Concepts to Pharmacy Compounding Author(s): Timko Robert J
Jan/Feb 2023 Pg. 22-23	The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone Author(s): Brunner Scott
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Sep/Oct 2020 Pg. 371-379	Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
Nov/Dec 2022 Pg. 444	PreScription: Compounded Drugs Often Become Manufactured Drugs Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 180	PreScription: Compounding for Drug Shortages Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 47-49	Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding Author(s): Martin Matt